Pleurotus ferulae polysaccharides improve the antitumor efficacy of therapeutic human papillomavirus dendritic cell-based vaccine

References

• Kalinski P. Dendritic cells in immunotherapy of established cancer: roles of signals 1, 2, 3 and 4. Curr Opin Investig Drugs. 10;2009:526–535.
   PubMedGoogle Scholar
• Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O’Garra A, Murphy KM. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science. 260;1993:547–549.
   PubMed Web of Science ®Google Scholar
• Macatonia SE, Hosken NA, Litton M, Vieira P, Hsieh CS, Culpepper JA, Wysocka M, Trinchieri G, Murphy KM, O’Garra A. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol. 154;1995:5071–5079.
   PubMed Web of Science ®Google Scholar
• Carreno BM, Becker-Hapak M, Huang A, Chan M, Alyasiry A, Lie WR, Aft RL, Cornelius LA, Trinkaus KM, Linette GP. IL-12p70-producing patient DC vaccine elicits Tc1-polarized immunity. J Clin Invest. 2013;123:3383–3394. doi:10.1172/JCI68395.
   PubMed Web of Science ®Google Scholar
• Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature. 2007;449:419–426. doi:10.1038/nature06175.
   PubMed Web of Science ®Google Scholar
• Rolinski J, Hus I. Breaking immunotolerance of tumors: A new perspective for dendritic cell therapy. J Immunotoxicol. 2014;11:311–318. doi:10.3109/1547691X.2013.865094.
   PubMed Web of Science ®Google Scholar
• Hansen M, Met O, Svane IM, Andersen MH. Cellular based cancer vaccines: type 1 polarization of dendritic cells. Curr Med Chem. 2012;19:4239–4246.
   PubMed Web of Science ®Google Scholar
• Sabado RL, Bhardwaj N. Dendritic cell immunotherapy. Ann N Y Acad Sci. 2013;1284:31–45. doi:10.1111/nyas.12125.
   PubMed Web of Science ®Google Scholar
• Koski GK, Koldovsky U, Xu S, Mick R, Sharma A, Fitzpatrick E, Weinstein S, Nisenbaum H, Levine BL, Fox K, et al. A novel dendritic cell-based immunization approach for the induction of durable Th1-polarized anti-HER-2/neu responses in women with early breast cancer. J Immunother. 2012;35:54–65. doi:10.1097/CJI.0b013e318235f512.
   PubMed Web of Science ®Google Scholar
• Vacchelli E, Vitale I, Eggermont A, Fridman WH, Fucikova J, Cremer I, Galon J, Tartour E, Zitvogel L, Kroemer G, et al. Trial watch: dendritic cell-based interventions for cancer therapy. Oncoimmunology. 2013;2:e25771. doi:10.4161/onci.25771.
   PubMed Web of Science ®Google Scholar
• Reed SG, Orr MT, Fox CB. Key roles of adjuvants in modern vaccines. Nat Med. 2013;19:1597–1608. doi:10.1038/nm.3409.
   PubMed Web of Science ®Google Scholar
• Awate S, Babiuk LA, Mutwiri G. Mechanisms of action of adjuvants. Front Immunol. 2013;4:114. doi:10.3389/fimmu.2013.00114.
   PubMed Web of Science ®Google Scholar
• Chen X, Yang L, Howard OM, Oppenheim JJ. Dendritic cells as a pharmacological target of traditional Chinese medicine. Cell Mol Immunol. 2006;3:401–410.
   PubMed Web of Science ®Google Scholar
• Li J, Li J, Zhang F. The immunoregulatory effects of Chinese herbal medicine on the maturation and function of dendritic cells. J Ethnopharmacol. 2015;171:184–195. doi:10.1016/j.jep.2015.05.050.
   PubMed Web of Science ®Google Scholar
• Li J, Zhang F, Li J. The immunoregulatory effects of traditional chinese medicine on treatment of asthma or asthmatic inflammation. Am J Chin Med. 2015;43:1059–1081. doi:10.1142/S0192415X15500615.
   PubMed Web of Science ®Google Scholar
• Alam N, Yoon KN, Lee JS, Cho HJ, Lee TS. Consequence of the antioxidant activities and tyrosinase inhibitory effects of various extracts from the fruiting bodies of Pleurotus ferulae. Saudi J Biol Sci. 2012;19:111–118. doi:10.1016/j.sjbs.2011.11.004.
   PubMed Web of Science ®Google Scholar
• Akyuz M, Kirbag S. Antimicrobial activity of Pleurotus eryngii var. ferulae grown on various agro-wastes. EurAsian J BioSc. 2009;3:58–63. doi:10.5053/ejobios.
   Google Scholar
• Choi D, Cha W, Kang S, Lee BR. Effect of Pleurotus ferulae extracts on viability of human lung cancer and cervical cancer cell lines. Biotechnol Bioprocess Eng. 2004;9:356–361. doi:10.1007/BF02933057.
   Web of Science ®Google Scholar
• Li J, Wang X, Wang W, Luo J, Aipire A, Li J, Zhang F. Pleurotus ferulae water extract enhances the maturation and function of murine bone marrow-derived dendritic cells through TLR4 signaling pathway. Vaccine. 2015;33:1923–1933. doi:10.1016/j.vaccine.2015.02.063.
   PubMed Web of Science ®Google Scholar
• Li J, Li J, Aipire A, Luo J, Yuan P, Zhang F. The combination of Pleurotus ferulae water extract and CpG-ODN enhances the immune responses and antitumor efficacy of HPV peptides pulsed dendritic cell-based vaccine. Vaccine. 2016;34:3568–3575. doi:10.1016/j.vaccine.2016.05.022.
   PubMed Web of Science ®Google Scholar
• Li J, Yuan P, Wang X, Aipire A, Li M, Yang J, Tao H, Ying T, Fu C, Wei X, et al. Purification, characterization and bioactivities of polysaccharides from Pleurotus ferulae. Food Funct. 2017;8:1905–1914. doi:10.1039/c7fo00227k.
   PubMed Web of Science ®Google Scholar
• Li J, Aipire A, Li J, Zhu H, Wang Y, Guo W, Li X, Yang J, Liu C. λ-Carrageenan improves the antitumor effect of dendritic cellbased vaccine. Oncotarget. 2017;8:29996–30007. doi:10.18632/oncotarget.15610.
   PubMedGoogle Scholar
• Aipire A, Li J, Yuan P, He J, Hu Y, Liu L, Feng X, Li Y, Zhang F, Yang J, et al. Glycyrrhiza uralensis water extract enhances dendritic cell maturation and antitumor efficacy of HPV dendritic cell-based vaccine. Sci Rep. 2017;7:43796. doi:10.1038/srep43796.
   PubMed Web of Science ®Google Scholar
• Vezys V, Yates A, Casey KA, Lanier G, Ahmed R, Antia R, Masopust D. Memory CD8 T-cell compartment grows in size with immunological experience. Nature. 2009;457:196–199. doi:10.1038/nature07486.
   PubMed Web of Science ®Google Scholar
• Takai S, Sabzevari H, Farsaci B, Schlom J, Greiner JW. Distinct effects of saracatinib on memory CD8+ T cell differentiation. J Immunol. 2012;188:4323–4333. doi:10.4049/jimmunol.1101439.
   PubMed Web of Science ®Google Scholar
• Coria LM, Ibanez AE, Pasquevich KA, Cobiello PL, Frank FM, Giambartolomei GH, Cassataro J. Brucella abortus Omp19 recombinant protein subcutaneously co-delivered with an antigen enhances antigen-specific T helper 1 memory responses and induces protection against parasite challenge. Vaccine. 2016;34:430–437. doi:10.1016/j.vaccine.2015.12.012.
   PubMed Web of Science ®Google Scholar
• Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol. 2009;9:162–174. doi:10.1038/nri2506.
   PubMed Web of Science ®Google Scholar
• Sica A, Bronte V. Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Invest. 2007;117:1155–1166. doi:10.1172/JCI31422.
   PubMed Web of Science ®Google Scholar
• Sales NS, Silva JR, Aps LRMM, Silva MO, Porchia BFMM, Ferreira LCS, Diniz MO. In vivo electroporation enhances vaccine-mediated therapeutic control of human papilloma virus-associated tumors by the activation of multifunctional and effector memory CD8+ T cells. Vaccine. 2017;35:7240–7249. doi:10.1016/j.vaccine.2017.11.011.
   PubMed Web of Science ®Google Scholar
• Zhang W, Yu X, Kwak M, Xu L, Zhang L, Yu Q, Jin JO. Maturation of dendritic cells by pullulan promotes anti-cancer effect. Oncotarget. 2016;7:44644–44659. doi:10.18632/oncotarget.10183.
   Google Scholar
• Zhang W, Okimura T, Xu L, Zhang L, Oda T, Kwak M, Yu Q, Jin J-O. Ascophyllan functions as an adjuvant to promote anti-cancer effect by dendritic cell activation. Oncotarget. 2016;7:19284–19298. doi:10.18632/oncotarget.8200.
   PubMedGoogle Scholar
• Vo MC, Lee HJ, Kim JS, Hoang MD, Choi NR, Rhee JH, Lakshmanan V-K, Shin S-J, Lee -J-J. Dendritic cell vaccination with a toll-like receptor agonist derived from mycobacteria enhances anti-tumor immunity. Oncotarget. 2015;6:33781–33790. doi:10.18632/oncotarget.5281.
   PubMedGoogle Scholar
• Quinn MA, Benedet JL, Odicino F, Maisonneuve P, Beller U, Creasman WT, Heintz AP, Ngan HY, Pecorelli S. Carcinoma of the cervix uteri. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet. 2006;95(Suppl 1):S43–103. doi:10.1016/S0020-7292(06)60030-1.
   Web of Science ®Google Scholar
• Sankaranarayanan R, Swaminathan R, Jayant K, Brenner H. An overview of cancer survival in Africa, Asia, the Caribbean and Central America: the case for investment in cancer health services. France: IARC scientific publications; 2011. p. 257–291.
   Google Scholar
• Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 55;2002:244–265.
   PubMed Web of Science ®Google Scholar
• Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst. 1995;87:796–802.
   PubMed Web of Science ®Google Scholar
• Clifford G, Franceschi S, Diaz M, Munoz N, Villa LL. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine. 2006;24(Suppl 3):S3/26–34. doi:10.1016/j.vaccine.2006.05.026.
   PubMedGoogle Scholar
• Kobayashi A, Weinberg V, Darragh T, Smith-McCune K. Evolving immunosuppressive microenvironment during human cervical carcinogenesis. Mucosal Immunol. 2008;1:412–420. doi:10.1038/mi.2008.33.
   PubMed Web of Science ®Google Scholar
• Kryczek I, Liu R, Wang G, Wu K, Shu X, Szeliga W, Vatan L, Finlayson E, Huang E, Simeone D, et al. FOXP3 defines regulatory T cells in human tumor and autoimmune disease. Cancer Res. 2009;69:3995–4000. doi:10.1158/0008-5472.CAN-08-3804.
   PubMed Web of Science ®Google Scholar
• Shao B, Wei X, Luo M, Yu J, Tong A, Ma X, Ye T, Deng H, Sang Y, Liang X, et al. Inhibition of A20 expression in tumor microenvironment exerts anti-tumor effect through inducing myeloid-derived suppressor cells apoptosis. Sci Rep. 2015;5:16437. doi:10.1038/srep16437.
   PubMed Web of Science ®Google Scholar
• Rossowska J, Pajtasz-Piasecka E, Anger N, Wojas-Turek J, Kicielinska J, Piasecki E, Duś D. Cyclophosphamide and IL-12-transduced DCs enhance the antitumor activity of tumor antigen-stimulated DCs and reduce Tregs and MDSCs number. J Immunother. 2014;37:427–439. doi:10.1097/CJI.0000000000000054.
   PubMed Web of Science ®Google Scholar
• Orsini E, Guarini A, Chiaretti S, Mauro FR, Foa R. The circulating dendritic cell compartment in patients with chronic lymphocytic leukemia is severely defective and unable to stimulate an effective T-cell response. Cancer Res. 2003;63:4497–4506.
   PubMed Web of Science ®Google Scholar
• Della Bella S, Gennaro M, Vaccari M, Ferraris C, Nicola S, Riva A, Clerici M, Greco M, Villa ML. Altered maturation of peripheral blood dendritic cells in patients with breast cancer. Br J Cancer. 2003;89:1463–1472. doi:10.1038/sj.bjc.6601243.
   PubMed Web of Science ®Google Scholar
• Troy AJ, Summers KL, Davidson PJ, Atkinson CH, Hart DN. Minimal recruitment and activation of dendritic cells within renal cell carcinoma. Clin Cancer Res. 1998;4:585–593.
   PubMed Web of Science ®Google Scholar
• Wang B, Wang X, Wen Y, Fu J, Wang H, Ma Z, Shi Y, Wang B. Suppression of established hepatocarcinoma in adjuvant only immunotherapy: alum triggers anti-tumor CD8+ T cell response. Sci Rep. 2015;5:17695. doi:10.1038/srep17695.
   PubMed Web of Science ®Google Scholar
• Lin KY, Guarnieri FG, Staveley-O’Carroll KF, Levitsky HI, August JT, Pardoll DM, Wu TC. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res. 1996;56:21–26.
   PubMed Web of Science ®Google Scholar